BioMerieux
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
43.32%
Market Cap
11.52 Bil.
P/E Ratio
32.74
Dividend Yield
0.89 %
Earnings per Share
3.37 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
| ResMed Inc. | 32.17 Bil. | 4.73 Bil. | 27.14 | +36.48 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 67.85 G | 0 Units |
| PRICE DETERMINATION TIME | 06/19/2026 / 10:32:18 AM | |
| DAILY VOLUME (UNITS) | 21 | |
| DAILY HIGH / LOW | 67.85 | 66.95 |
| PREV. DAY'S PRICE | 67.35 | (06/18) |
| CHANGE DAY BEFORE | +0.50 | 0.74 % |
| 52 WEEK HIGH / LOW | 131 (08/19) | 67 (06/17) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 4.94 | 4.46 | 3.37 | 3.67 | 3.03 |
| DIVIDENDS PER SHARE | 1.23 | 1.11 | 0.98 | 0.90 | 0.85 |
| DIVIDEND YIELD IN % | - | - | 0.89 % | 0.87 % | 0.84 % |
| DIVIDEND GROWTH IN % | - | - | 8.89 % | 5.88 % | 0.00 % |
| PRICE - EARNINGS RATIO | 13.72 | 15.20 | 32.74 | 28.24 | 33.24 |
| PRICE - BOOK RATIO | - | - | 3.17 | 2.90 | 3.17 |
| PRICE - SALES RATIO | - | - | 3.22 | 3.09 | 3.25 |
| PRICE - CASH FLOW RATIO | - | - | 16.63 | 18.42 | 26.83 |
Master Data
| WKN | A2DXZH |
| ISIN | FR0013280286 |
| SYMBOL | EYWN |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | BioMerieux |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 118.15 Mil. |
| MARKET CAPITALISATION | 11.52 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -4.35 % | -5.77 % | -28.57 % | -37.56 % | -43.32 % | -27.54 % | -26.34 % | -38.87 % |
| HIGH | 70.05 | 74.85 | 94.75 | 115.80 | 131.00 | 131.00 | 134.95 | 115.80 |
| LOW | 67.00 | 67.00 | 67.00 | 67.00 | 67.00 | 67.00 | 67.00 | 67.00 |
Dividend
per share
Company profile
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
Structured products for BioMerieux
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.